NCT04118374View on ClinicalTrials.gov

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 29, 2019

Primary Completion Date

June 21, 2024

Study Completion Date

June 21, 2024

Conditions
Diabetes Mellitus, Type 1
Interventions
OTHER

Standard Carb Diet

Approximately 50% of caloric intake will come from carbohydrate consumption.

OTHER

Low Carb Diet

Approximately 25% of caloric intake will come from carbohydrate consumption.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT04118374 - A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes | Biotech Hunter | Biotech Hunter